DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Depakene (Valproic Acid) - Disability - Suspected Cause - Side Effect Reports

 
 



Index of reports > Disability (19)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Depakene (Valproic Acid) disability. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Depakene side effects in 19 year old male

Reported by a health professional (non-physician/pharmacist) from Cameroon on 2012-08-10

Patient: 19 year old male

Reactions: Disability

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in 81 year old female

Reported by a pharmacist from Portugal on 2012-08-03

Patient: 81 year old female

Reactions: Oedema Peripheral, Blister

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Trimetazidine Hydrochloride; Esclerobion; Daflon



Possible Depakene side effects in 7 year old male

Reported by a health professional (non-physician/pharmacist) from China on 2012-06-21

Patient: 7 year old male

Reactions: Hypoacusis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in 20 year old female

Reported by a health professional (non-physician/pharmacist) from China on 2012-06-13

Patient: 20 year old female

Reactions: Hypoacusis, Vomiting, Dizziness

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Peplomycin



Possible Depakene side effects in 39 year old female

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-06-08

Patient: 39 year old female

Reactions: Disturbance in Attention, Somnolence, Aggression

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Lamotrigine
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1975-03-01

Tegretol
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1975-03-01

Depakene
    Dosage: extended release
    Administration route: Oral
    Indication: Epilepsy
    Start date: 1975-03-01

Other drugs received by patient: Diazepam; Polyethylene Glycol; Antiepileptics; Naproxen; Phenobarbital TAB



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-05-31

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Daydreaming, Disturbance in Attention, Mental Retardation, Somnolence, Aggression

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Tegretol-XR
    Dosage: 100-200 mg
    Indication: Epilepsy
    Start date: 1975-03-01

Depakene
    Dosage: 600-750 mg
    Indication: Epilepsy
    Start date: 1975-03-01

Lamictal
    Dosage: 75-100 mg
    Indication: Epilepsy
    Start date: 1975-03-01

Other drugs received by patient: Diazepam; Transipeg; Naproxen



Possible Depakene side effects in 7 year old male

Reported by a health professional (non-physician/pharmacist) from China on 2012-04-27

Patient: 7 year old male

Reactions: Hypoacusis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-04-03

Patient: female

Reactions: Congenital Hand Malformation, Blindness Congenital, Foetal Exposure During Pregnancy, Congenital Anomaly, Congenital Hearing Disorder, Heart Disease Congenital

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Depakene



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-23

Patient: female, weighing 2.0 kg (4.4 pounds)

Reactions: LOW Birth Weight Baby, Atrial Septal Defect, Foetal Anticonvulsant Syndrome, Respiratory Disorder, Joint Contracture, Ventricular Septal Defect, Failure To Thrive, Limb Reduction Defect, Foetal Growth Restriction, Hypotonia, Patent Ductus Arteriosus, Wrist Deformity

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Tegretol
    Dosage: 1200 mg, daily
    Indication: Infantile Spasms

Depakene
    Dosage: 1400 mg, daily
    Indication: Infantile Spasms
    End date: 2010-03-17

Phenobarbital TAB
    Dosage: 140 mg, daily
    Indication: Infantile Spasms



Possible Depakene side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-20

Patient: female, weighing 2.0 kg (4.4 pounds)

Reactions: LOW Birth Weight Baby, Atrial Septal Defect, Foetal Anticonvulsant Syndrome, Respiratory Disorder, Joint Contracture, Ventricular Septal Defect, Failure To Thrive, Limb Reduction Defect, Foetal Growth Restriction, Hypotonia, Patent Ductus Arteriosus, Wrist Deformity

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Phenobarbital TAB
    Dosage: 140 mg, daily
    Indication: Infantile Spasms

Depakene
    Dosage: 1400 mg, daily
    Indication: Infantile Spasms
    End date: 2010-03-17

Tegretol
    Dosage: 1200 mg, daily
    Indication: Infantile Spasms



Possible Depakene side effects in female

Reported by a consumer/non-health professional from Brazil on 2012-02-17

Patient: female, weighing 110.0 kg (242.0 pounds)

Reactions: Confusional State, Pneumonia, Diabetic Complication, Secretion Discharge, Somnolence, Speech Disorder, Blood Glucose Decreased, Eyelid Function Disorder, Tongue Disorder

Adverse event resulted in: death, hospitalization, disablity

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Diazepam; Captopril; Haloperidol; Nortriptyline HCL; Insulin



Possible Depakene side effects in 37 year old female

Reported by a physician from Austria on 2012-02-03

Patient: 37 year old female

Reactions: Pleurothotonus, Blood Creatine Phosphokinase Increased

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Clozapine
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-21
    End date: 2011-12-22

Clozapine
    Start date: 2011-12-28

Clozapine
    Start date: 2011-12-23
    End date: 2011-12-27

Lorazepam
    Dosage: dosage 4, 5 (unit unspecified), end date was 05-jan
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-14

Clozapine
    Start date: 2011-12-22
    End date: 2011-12-23

Depakene
    Dosage: dosage 1000 (unit unspecified)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-14

Haldol
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-14
    End date: 2011-12-21

Lithium Carbonate
    Dosage: dosage 900 (unit unspecified)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-14



Possible Depakene side effects in male

Reported by a physician from Japan on 2012-01-05

Patient: male

Reactions: Drug Eruption, Pruritus, Lymphadenopathy, Pyrexia, Erythema, Acute Generalised Exanthematous Pustulosis, Gamma-Glutamyltransferase Increased, C-Reactive Protein Increased, White Blood Cell Count Increased, Dermatitis Acneiform, Rash Pustular, Swelling Face, Rash Papular, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Rash, Eosinophil Count Increased, Dermatitis Exfoliative

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Abilify
    Dosage: 6mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Depakene
    Dosage: 1200mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Halcion
    Dosage: .25mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Lamictal
    Dosage: 25mg alternate days
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2011-10-12
    End date: 2011-10-24

Lamictal
    Dosage: 25mg per day
    Administration route: Oral
    Start date: 2011-10-25
    End date: 2011-11-12

Fluvoxamine Maleate
    Dosage: 225mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20

Tetramide
    Dosage: 20mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Lendormin
    Dosage: .25mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Akineton
    Dosage: 3mg per day
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Rohypnol
    Dosage: 2mg per day
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21



Possible Depakene side effects in male

Reported by a physician from Japan on 2011-12-20

Patient: male

Reactions: Drug Eruption, Lymphadenopathy, Pyrexia, Erythema, Acute Generalised Exanthematous Pustulosis, C-Reactive Protein Increased, Gamma-Glutamyltransferase Increased, White Blood Cell Count Increased, Dermatitis Acneiform, Rash Pustular, Swelling Face, Alanine Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Rash Papular, Rash, Eosinophil Count Increased, Dermatitis Exfoliative

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Rohypnol
    Dosage: 2mg per day
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Lamictal
    Dosage: 25mg alternate days
    Administration route: Oral
    Indication: Bipolar Disorder
    Start date: 2011-10-12
    End date: 2011-10-24

Depakene
    Dosage: 1200mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Lamictal
    Administration route: Oral
    Start date: 2011-10-25
    End date: 2011-11-12

Halcion
    Dosage: .25mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Lendormin
    Dosage: .25mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Fluvoxamine Maleate
    Dosage: 225mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20

Tetramide
    Dosage: 20mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Abilify
    Dosage: 6mg per day
    Administration route: Oral
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21

Akineton
    Dosage: 3mg per day
    Indication: Depression
    Start date: 2011-07-20
    End date: 2011-11-21



Possible Depakene side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-20

Patient: male, weighing 91.7 kg (201.8 pounds)

Reactions: Agitation, Economic Problem, Pruritus, Obsessive-Compulsive Disorder, Conversion Disorder, Dementia, Coma, Acidosis, Oedema Peripheral, Cardiac Failure Congestive, Diabetes Mellitus Inadequate Control, Faecal Incontinence, Abnormal Behaviour, General Physical Health Deterioration, Body Temperature Decreased, Verbal Abuse, Tremor, Alcohol Use, Emotional Distress, Hyperammonaemia, Vitamin D Decreased, Pancreatitis, Sleep Apnoea Syndrome, Atelectasis, Nicotine Dependence, Deafness Bilateral, Adverse Drug Reaction, Ketonuria, Hyperammonaemic Encephalopathy, Pupils Unequal, Cerebellar Atrophy, Anhedonia, Intervertebral Disc Disorder, Anger, Sinusitis, Gastrooesophageal Reflux Disease, Thrombocytopenia, Frontotemporal Dementia, Cataract, N-Acetylglutamate Synthase Deficiency, Cerebral Atrophy, Cognitive Disorder, Intraocular Lens Implant, Blood Lactic Acid Increased, Hyperlipidaemia, Osteoarthritis, Anxiety, Renal Failure, Bipolar Disorder, Hypothyroidism, Physical Disability, Asthenia

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Depakene
    Dosage: unknown dose when started
    Indication: Convulsion Prophylaxis
    Start date: 1982-01-01

Depakene
    Dosage: dose increased to 4000mg/day
    End date: 2006-01-01

Depakene
    Start date: 2007-01-01
    End date: 2010-01-01

Depakene
    Start date: 2006-01-01
    End date: 2007-01-01

Other drugs received by patient: Mysoline; Seroquel; Celexa; Seoquil; Phenobarbital TAB



Possible Depakene side effects in 22 year old female

Reported by a physician from Switzerland on 2011-12-19

Patient: 22 year old female, weighing 90.0 kg (198.0 pounds)

Reactions: Cheyne-Stokes Respiration, Rhabdomyolysis, Disseminated Intravascular Coagulation, Encephalitis, Pyrexia, Weight Increased, Multi-Organ Failure, Hypertriglyceridaemia, Renal Failure Acute, Vomiting, Cholestatic Liver Injury, International Normalised Ratio Increased, Incorrect Dose Administered, Troponin T Increased, Drug Rash With Eosinophilia and Systemic Symptoms, Renal Tubular Necrosis, Cardiovascular Disorder, Rash Maculo-Papular

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Lamotrigine
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-08-26
    End date: 2011-09-04

Depakene
    Dosage: 500mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-06-01
    End date: 2011-09-06

Propofol
    Dosage: 6846mg per day
    Indication: Anaesthesia
    Start date: 2011-09-05
    End date: 2011-09-07



Possible Depakene side effects in 42 year old female

Reported by a pharmacist from Spain on 2011-12-05

Patient: 42 year old female

Reactions: Intermittent Claudication, Aphasia, Ataxia, Mobility Decreased

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Depakene

Other drugs received by patient: Doxorubicin Hydrochloride; Trabectedin



Possible Depakene side effects in 22 year old female

Reported by a physician from Switzerland on 2011-11-28

Patient: 22 year old female, weighing 90.0 kg (198.0 pounds)

Reactions: Cheyne-Stokes Respiration, Hepatic Function Abnormal, Rhabdomyolysis, Disseminated Intravascular Coagulation, Encephalitis, Pyrexia, Weight Increased, Multi-Organ Failure, Hypertriglyceridaemia, Renal Failure Acute, Vomiting, Drug Hypersensitivity, Incorrect Dose Administered, International Normalised Ratio Increased, Troponin T Increased, Renal Tubular Necrosis, Rash Maculo-Papular, Cardiovascular Disorder

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Propofol
    Indication: Anaesthesia
    Start date: 2011-09-01
    End date: 2011-09-01

Lamotrigine
    Dosage: 25mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-08-26
    End date: 2011-09-04

Depakene
    Dosage: 500mg per day
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-06-01



Possible Depakene side effects in male

Reported by a physician from France on 2011-11-15

Patient: male, weighing 70.0 kg (154.0 pounds)

Reactions: Lymphadenopathy, Blood Creatine Phosphokinase Increased, Respiratory Disorder, High Density Lipoprotein Increased, Urinary Incontinence, Visual Acuity Reduced, Ulcerative Keratitis, Pyrexia, Transaminases Increased, Obstructive Uropathy, C-Reactive Protein Increased, Dermatitis Bullous, Acute Respiratory Distress Syndrome, Mucous Membrane Disorder, Cough, Back Pain, Medical Device Complication, Dysphagia, Toxic Epidermal Necrolysis, Corneal Opacity, Prothrombin Time Ratio Decreased, Blood Creatine Phosphokinase MB Increased, Heart Rate Decreased, Rash Erythematous, Renal Colic, Corneal Neovascularisation, Skin Exfoliation, Eye Discharge, Scab, Symblepharon, Nephrolithiasis, Photophobia, Microlithiasis, Bone Marrow Failure, Thrombocytopenia, Renal Failure Acute, Cataract, Epilepsy, Iris Adhesions, Alopecia, Lacrimation Decreased, Gait Disturbance, Asthenia, Leukopenia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Depakene
    Dosage: 1 g daily
    Administration route: Oral
    Indication: Partial Seizures
    Start date: 2004-11-23
    End date: 2004-11-23

Trileptal
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Partial Seizures
    Start date: 2005-02-14
    End date: 2005-02-21

Depakene
    Dosage: 1.5 g daily
    Start date: 2004-11-24
    End date: 2005-02-21

Depakene
    Dosage: 1.6 g daily
    Indication: Partial Seizures
    End date: 2004-11-22

Aspegic 325
    Indication: Influenza Like Illness
    Start date: 2005-02-01

Other drugs received by patient: Levetiracetam; Clobazam; Topiramate; Clonazepam

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017